High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: A randomized, placebo-controlled, crossover study

Increased dosing of nonsedating antihistamines is recommended by the current European Academy of Allergology and Clinical Immunology/Global Allergy and Asthma European Network/European Dermatology Forum guidelines on patients with acquired cold urticaria (ACU) who do not respond satisfactorily to th...

Full description

Saved in:
Bibliographic Details
Published in:Journal of allergy and clinical immunology 2009-03, Vol.123 (3), p.672-679
Main Authors: Siebenhaar, Frank, Degener, Franziska, Zuberbier, Torsten, Martus, Peter, Maurer, Marcus
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
Allergy and Immunology
antihistamine
Biological and medical sciences
chronic
Cold
Cold Temperature
Cross-Over Studies
desloratadine
Disease
Double-Blind Method
Drug therapy
Female
Fundamental and applied biological sciences. Psychology
Fundamental immunology
Histamine Antagonists - administration & dosage
Histamine Antagonists - adverse effects
Humans
Immunopathology
Loratadine - administration & dosage
Loratadine - adverse effects
Loratadine - analogs & derivatives
Male
Medical sciences
Middle Aged
objective
Patient safety
Prospective Studies
Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis
Semiconductors
Substance abuse treatment
Urticaria
Urticaria - drug therapy
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!